InMed Pharmaceuticals Inc (NAS:INM)
$ 0.225899 -0.009501 (-4.04%) Market Cap: 1.89 Mil Enterprise Value: -4.56 Mil PE Ratio: 0 PB Ratio: 0.13 GF Score: 28/100

InMed Pharmaceuticals Inc at Emerging Growth Conference Transcript

Mar 08, 2023 / 05:30PM GMT
Release Date Price: $1.34 (+7.20%)
Ana Berry
Berry Media, Inc - Moderator

Welcome back, everyone. Next up, we have InMed Pharmaceuticals Inc., trades on the Nasdaq under the symbol INM and as a biopharmaceutical company that specializes in developing novel therapies for diseases with high unmet medical need through the research and development of the extensive pharmacology of rare cannabinoids, coupled with diverse manufacturing technologies to provide rare cannabinoids to the health and wellness sector.

Please welcome its CEO, Eric Adams. Welcome, Eric, happy to have you on our conference today.

Eric Adams
InMed Pharmaceuticals Inc. - CEO & President

Thank you for having me today. Appreciate it.

Ana Berry
Berry Media, Inc - Moderator

All right. Whenever you're ready, Eric. The floor is yours.

Eric Adams
InMed Pharmaceuticals Inc. - CEO & President

Great. Thank you. So I just want to walk everyone through a brief introduction to the company and some of the technologies that we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot